Personal information

No personal information available

Activities

Collapse all

Works (4)

Gut microbiome studies in CKD: opportunities, pitfalls and therapeutic potential

Nature Reviews Nephrology
2023-02 | Journal article
DOI: 10.1038/s41581-022-00647-z
Contributors: Hubert Krukowski; Sophie Valkenburg; Avra-Melina Madella; Johan Garssen; Jeroen van Bergenhenegouwen; Saskia Adriana Overbeek; Geert R. B. Huys; Jeroen Raes; Griet Glorieux
Source: check_circle
Crossref

The Modulatory Effects of Fatty Acids on Cancer Progression

Biomedicines
2023-01-19 | Journal article
DOI: 10.3390/biomedicines11020280
Contributors: Annemarie J. F. Westheim; Lara M. Stoffels; Ludwig J. Dubois; Jeroen van Bergenhenegouwen; Ardy van Helvoort; Ramon C. J. Langen; Ronit Shiri-Sverdlov; Jan Theys
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Human Milk Oligosaccharide 2′-Fucosyllactose Inhibits Ligand Binding to C-Type Lectin DC-SIGN but Not to Langerin

International Journal of Molecular Sciences
2022-11-25 | Journal article
DOI: 10.3390/ijms232314745
Contributors: Reshmi Mukherjee; Victor J. Somovilla; Fabrizio Chiodo; Sven Bruijns; Roland J. Pieters; Johan Garssen; Yvette van Kooyk; Aletta D. Kraneveld; Jeroen van Bergenhenegouwen
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Human Milk Oligosaccharide 2’-fucosyllactose inhibits ligand binding to C-type lectin DC-SIGN but not to Langerin

2022-07-27 | Preprint
DOI: 10.1101/2022.07.27.501236
Contributors: Reshmi Mukherjee; Victor J. Somovilla; Fabrizio Chiodo; Sven Bruijns; Roland J Pieters; Johan Garssen; Yvette van Kooyk; Aletta D Kraneveld; Jeroen van Bergenhenegouwen
Source: check_circle
Crossref

Peer review (1 review for 1 publication/grant)

Review activity for Cancer immunology and immunotherapy. (1)
How many people are using ORCID?